News
An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...
President Trump escalated his demands that pharma firms lower U.S. prices in line with what other countries pay, sending ...
The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...
In early June, a MAGA influencer named Chuck Callesto launched a social media assault on Sen. Bill Cassidy, a Louisiana ...
The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...
Jay Bhattacharya’s tenure as NIH director has seen health disparities research swept up in the Trump administration’s attack ...
The reshaping of the CDC's vaccine advisory panel has continued, with the apparent barring of reps of medical associations ...
Senators from both parties endorsed a $400 million increase to the budget of the National Institutes of Health on Thursday ...
Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...
The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.
Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback